GSK gets bumper vaccine orders

Pharmaceutical giant GlaxoSmithKline yesterday announced it has received government contracts for a further 96m doses of its swine flu vaccine. Earlier this year the group said it had government-signed contracts for the vaccine and a $250m (£148m) deal with the US government to provide swine flu products. Analysts have said they expect GSK to reap a £2.6bn windfall from the swine flu pandemic.